Oaktree Acquisition Corp. III Life Sciences (OACC) Earnings History
Profitable2 years of earnings data (2024–2025) · Positive TTM net income
Loading earnings history...
Oaktree Acquisition Corp. III Life Sciences (OACC) Earnings Overview
As of June 28, 2026, Oaktree Acquisition Corp. III Life Sciences (OACC) reported trailing twelve-month net income of $7M, reflecting +453.5% year-over-year growth. The company earned $0.34 per diluted share over the past four quarters.
Looking at the long-term picture, OACC's historical earnings data spans multiple years. The company achieved its highest annual net income of $7M in fiscal 2025, representing a new all-time high.
Oaktree Acquisition Corp. III Life Sciences maintains positive profitability with. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including RLAY (-$273M net income, -1800.6% margin), BCTX (-$37M net income), RXRX (-$560M net income, -863.4% margin), OACC has comparable earnings metrics. Compare OACC vs RLAY →
OACC Earnings vs Peers
Earnings metrics vs comparable public companies
OACC Historical Earnings Data (2024–2025)
2 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $7M | +273607.2% | -$1M | $0.30 | - | - |
| 2024 | $2,663 | - | $-703 | $0.05 | - | - |
Download Data
Export OACC earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
2+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
OACC — Frequently Asked Questions
Quick answers to the most common questions about buying OACC stock.
What is OACC earnings per share (EPS)?
OACC trailing twelve-month (TTM) diluted EPS is $0.34, reflecting +453.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2024 to 2025 is available in the table on this page.
What is Oaktree Acquisition Corp. III Life Sciences's net income?
Oaktree Acquisition Corp. III Life Sciences (OACC) trailing twelve-month net income is $7M as of 2025. Earnings grew +453.5% year-over-year. Oaktree Acquisition Corp. III Life Sciences has been profitable for 2 consecutive years.
Is OACC profitable?
Yes, OACC is profitable with a TTM net income of $7M and a net profit margin of N/A. Oaktree Acquisition Corp. III Life Sciences has generated profits for 2 consecutive years.
What is OACC's earnings growth rate?
OACC compound annual EPS growth rates (CAGR): 1-Year: +453.5%, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2024 to 2025.
What are OACC's profit margins?
Oaktree Acquisition Corp. III Life Sciences net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is +3.8%.
Is OACC growing earnings?
Yes, OACC earnings are accelerating — EPS growth of +453.5% exceeds the 5-year CAGR of N/A. TTM net income reached $7M. Earnings momentum is strengthening.
What was OACC's best earnings year?
Oaktree Acquisition Corp. III Life Sciences's highest annual net income on record is $7M, achieved in fiscal year 2025. Earnings history on this page spans 2024 to 2025 and includes all annual and quarterly figures.
What were OACC's earnings last quarter?
OACC's most recent reported quarter was Q1 2026. Net income was $1M with diluted EPS of $0.06. For a full breakdown of all quarters, see the quarterly earnings table on this page.